ATE243198T1 - Verbindungen mit leicht spaltbaren bindungen zur inaktivierung von pathogenen - Google Patents
Verbindungen mit leicht spaltbaren bindungen zur inaktivierung von pathogenenInfo
- Publication number
- ATE243198T1 ATE243198T1 AT98901776T AT98901776T ATE243198T1 AT E243198 T1 ATE243198 T1 AT E243198T1 AT 98901776 T AT98901776 T AT 98901776T AT 98901776 T AT98901776 T AT 98901776T AT E243198 T1 ATE243198 T1 AT E243198T1
- Authority
- AT
- Austria
- Prior art keywords
- compounds
- pathogens
- methods
- claveable
- inactivation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
- A61L2/0082—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using chemical substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/02—Blood transfusion apparatus
- A61M1/0209—Multiple bag systems for separating or storing blood components
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/28—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof characterised by their form or physical properties
- B01J20/28014—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof characterised by their form or physical properties characterised by their form
- B01J20/28033—Membrane, sheet, cloth, pad, lamellar or mat
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D219/00—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
- C07D219/04—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
- C07D219/08—Nitrogen atoms
- C07D219/10—Nitrogen atoms attached in position 9
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/576—Six-membered rings
- C07F9/64—Acridine or hydrogenated acridine ring systems
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US77988597A | 1997-01-06 | 1997-01-06 | |
US77983097A | 1997-01-07 | 1997-01-07 | |
US4369697P | 1997-04-15 | 1997-04-15 | |
PCT/US1998/000532 WO1998030545A1 (en) | 1997-01-06 | 1998-01-06 | Frangible compounds for pathogen inactivation |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE243198T1 true ATE243198T1 (de) | 2003-07-15 |
Family
ID=27366374
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT98901776T ATE243198T1 (de) | 1997-01-06 | 1998-01-06 | Verbindungen mit leicht spaltbaren bindungen zur inaktivierung von pathogenen |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP1021414B1 (de) |
JP (2) | JP4551502B2 (de) |
CN (2) | CN101676268B (de) |
AT (1) | ATE243198T1 (de) |
AU (1) | AU744089C (de) |
CA (1) | CA2276532C (de) |
DE (1) | DE69815703T2 (de) |
ES (1) | ES2196530T3 (de) |
HK (2) | HK1188441A1 (de) |
WO (1) | WO1998030545A1 (de) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2196530T3 (es) * | 1997-01-06 | 2003-12-16 | Cerus Corp | Compuestos de ruptura para inactivar patogenos. |
AU745209B2 (en) | 1998-01-06 | 2002-03-14 | Cerus Corporation | Methods for quenching pathogen inactivators in biological materials |
US6281225B1 (en) | 1998-06-11 | 2001-08-28 | Cerus Corporation | Inhibiting proliferation of arterial smooth muscle cells |
US6403359B1 (en) | 1998-09-25 | 2002-06-11 | V. I. TECHNOLOGIES, Inc. | Solid phase quenching systems |
US6150109A (en) | 1999-01-25 | 2000-11-21 | V. I. TECHNOLOGIES, Inc. | Lipophilic quenching of viral inactivating agents |
JP2003534383A (ja) * | 2000-05-31 | 2003-11-18 | セラス コーポレイション | 免疫原性が減少した赤血球の病原体不活性化溶液の調製 |
US9044523B2 (en) | 2000-06-15 | 2015-06-02 | Terumo Bct, Inc. | Reduction of contaminants in blood and blood products using photosensitizers and peak wavelengths of light |
DE10051628B4 (de) * | 2000-10-18 | 2007-06-06 | Fresenius Hemocare Beteiligungs Gmbh | Einzelsträngiges Oligonukleotid und dessen Verwendung |
CA2434256A1 (en) * | 2000-12-21 | 2003-07-31 | David Cook | Methods for inactivation of pathogens in biological materials |
US7695725B2 (en) | 2003-02-06 | 2010-04-13 | Aduro Biotech | Modified free-living microbes, vaccine compositions and methods of use thereof |
EP1592441B1 (de) | 2003-02-06 | 2012-04-11 | Aduro Biotech | Listerien deren eindringen in nicht-phagozytische zellen abgeschwächt ist, impfstoffe, die diese listerien enthalten und deren verwendungen |
JP4839209B2 (ja) * | 2003-02-06 | 2011-12-21 | アンザ セラピューティクス,インコーポレイテッド | 改変された自由生活微生物、ワクチン組成物、およびそれらの使用方法 |
US7842289B2 (en) | 2003-12-24 | 2010-11-30 | Aduro Biotech | Recombinant nucleic acid molecules, expression cassettes, and bacteria, and methods of use thereof |
JP5346468B2 (ja) | 2004-10-29 | 2013-11-20 | シーラス コーポレイション | 赤血球不活性化プロセスのための改善されたクエンチング方法 |
CA2720824C (en) | 2008-04-09 | 2021-09-14 | Cerus Corporation | Improved quenching methods for red blood cell pathogen inactivation |
AU2014216178B2 (en) | 2013-02-15 | 2018-06-28 | KALA BIO, Inc. | Therapeutic compounds and uses thereof |
CA2900680C (en) | 2013-02-20 | 2021-08-10 | Kala Pharmaceuticals, Inc. | Quinoline and quinazoline compounds and uses thereof for treating and/or preventing diseases |
US9688688B2 (en) | 2013-02-20 | 2017-06-27 | Kala Pharmaceuticals, Inc. | Crystalline forms of 4-((4-((4-fluoro-2-methyl-1H-indol-5-yl)oxy)-6-methoxyquinazolin-7-yl)oxy)-1-(2-oxa-7-azaspiro[3.5]nonan-7-yl)butan-1-one and uses thereof |
NZ719185A (en) | 2013-11-01 | 2017-11-24 | Kala Pharmaceuticals Inc | Crystalline forms of therapeutic compounds and uses thereof |
US9890173B2 (en) | 2013-11-01 | 2018-02-13 | Kala Pharmaceuticals, Inc. | Crystalline forms of therapeutic compounds and uses thereof |
CN104788373A (zh) * | 2015-05-06 | 2015-07-22 | 武汉大学 | 化合物s-303盐酸盐的合成方法 |
AU2016283389B2 (en) | 2015-06-26 | 2022-09-15 | Cerus Corporation | Cryoprecipitate compositions and methods of preparation thereof |
CN104991033A (zh) * | 2015-08-05 | 2015-10-21 | 上海海虹实业(集团)巢湖今辰药业有限公司 | 一种采用一测多评法测定川芎挥发油成分的方法 |
US10799533B2 (en) | 2015-10-23 | 2020-10-13 | Cerus Corporation | Plasma compositions and methods of use thereof |
CA3036340A1 (en) | 2016-09-08 | 2018-03-15 | Kala Pharmaceuticals, Inc. | Crystalline forms of therapeutic compounds and uses thereof |
WO2018048747A1 (en) | 2016-09-08 | 2018-03-15 | Kala Pharmaceuticals, Inc. | Crystalline forms of therapeutic compounds and uses thereof |
US10336767B2 (en) | 2016-09-08 | 2019-07-02 | Kala Pharmaceuticals, Inc. | Crystalline forms of therapeutic compounds and uses thereof |
EA201991506A1 (ru) * | 2016-12-23 | 2020-01-23 | Сирус Корпорейшн | Системы и способы для тестирования и скрининга с использованием связанных с соединениями субстратов |
EP3589297A1 (de) | 2017-03-03 | 2020-01-08 | Cerus Corporation | Kits und verfahren zur herstellung von pathogen-inaktivierten thrombozytenzusammensetzungen |
CN116571191A (zh) | 2017-12-29 | 2023-08-11 | 塞鲁斯公司 | 用于处理生物流体的***和方法 |
CN114269394A (zh) | 2019-06-28 | 2022-04-01 | 塞鲁斯公司 | 用于实现生物流体处理装置的***和方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994020090A1 (en) * | 1993-03-17 | 1994-09-15 | Steritech, Inc. | Decontaminating clinical samples |
US5691132A (en) * | 1994-11-14 | 1997-11-25 | Cerus Corporation | Method for inactivating pathogens in red cell compositions using quinacrine mustard |
DE4444045C2 (de) * | 1994-12-10 | 1997-04-17 | Behringwerke Ag | Verfahren zur Inaktivierung von Viren mit Hilfe von Acridin oder Acridinderivaten |
EP0773716A4 (de) * | 1995-06-07 | 1999-08-04 | Cerus Corp | Behandlung von lösungen roter blutkörperchen mit antivralen wirkstoffen |
ES2196530T3 (es) * | 1997-01-06 | 2003-12-16 | Cerus Corp | Compuestos de ruptura para inactivar patogenos. |
-
1998
- 1998-01-06 ES ES98901776T patent/ES2196530T3/es not_active Expired - Lifetime
- 1998-01-06 CA CA002276532A patent/CA2276532C/en not_active Expired - Fee Related
- 1998-01-06 AU AU58217/98A patent/AU744089C/en not_active Expired
- 1998-01-06 AT AT98901776T patent/ATE243198T1/de not_active IP Right Cessation
- 1998-01-06 DE DE69815703T patent/DE69815703T2/de not_active Expired - Lifetime
- 1998-01-06 EP EP98901776A patent/EP1021414B1/de not_active Expired - Lifetime
- 1998-01-06 CN CN2009101633119A patent/CN101676268B/zh not_active Expired - Lifetime
- 1998-01-06 JP JP53119998A patent/JP4551502B2/ja not_active Expired - Lifetime
- 1998-01-06 CN CN988027348A patent/CN1248245B/zh not_active Expired - Lifetime
- 1998-01-06 WO PCT/US1998/000532 patent/WO1998030545A1/en active IP Right Grant
-
2000
- 2000-09-20 HK HK10109160.3A patent/HK1188441A1/xx not_active IP Right Cessation
- 2000-09-20 HK HK00105911.5A patent/HK1026702A1/xx not_active IP Right Cessation
-
2009
- 2009-12-17 JP JP2009286996A patent/JP5244083B2/ja not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
CN1248245B (zh) | 2012-07-04 |
JP4551502B2 (ja) | 2010-09-29 |
JP2010095527A (ja) | 2010-04-30 |
CA2276532C (en) | 2008-06-17 |
EP1021414B1 (de) | 2003-06-18 |
AU5821798A (en) | 1998-08-03 |
AU744089B2 (en) | 2002-02-14 |
WO1998030545A1 (en) | 1998-07-16 |
CN101676268A (zh) | 2010-03-24 |
ES2196530T3 (es) | 2003-12-16 |
CN101676268B (zh) | 2013-09-25 |
HK1188441A1 (en) | 2014-05-02 |
JP5244083B2 (ja) | 2013-07-24 |
DE69815703T2 (de) | 2004-06-03 |
HK1026702A1 (en) | 2000-12-22 |
EP1021414A1 (de) | 2000-07-26 |
CA2276532A1 (en) | 1998-07-16 |
CN1248245A (zh) | 2000-03-22 |
AU744089C (en) | 2003-07-31 |
JP2001508449A (ja) | 2001-06-26 |
DE69815703D1 (de) | 2003-07-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE243198T1 (de) | Verbindungen mit leicht spaltbaren bindungen zur inaktivierung von pathogenen | |
ATE287210T1 (de) | Behandlung von lösungen roter blutkörperchen mit antiviralen wirkstoffen | |
DE69328685D1 (de) | Verfahren zur inaktivierung von bakterien in blutpräparaten mit hilfe von methoxypsoralen | |
DE69328777D1 (de) | Dekontaminierung von Plättchen mit 8-Methoxypsoralen | |
AU9058091A (en) | Preparation of nucleic acid samples | |
IL197686A0 (en) | Pharmaceutical compositions containing alpha-4 integrin antagonists and uses thereof in the treatment of multiple myeloma and diseases associated therewith | |
DE60135498D1 (de) | Produktion von ganzen Antikörpern in prokaryontischen Zellen | |
DE60212964D1 (de) | Zusammensetzungen zur behandlung von tierischen krankheiten und syndromen mit transferfaktor | |
EP1362127A4 (de) | Serpin-arzneistoffe zur behandlung einer hiv-infektion und verfahren zu deren verwendung | |
DE60136826D1 (de) | Verwendung von asiatsäure oder asiaticosid zur behandlung von krebs | |
ES2168361T3 (es) | Secuencias de adn para metaloproteasas de la matriz, su preparacion y empleo. | |
PT84089A (en) | Dna sequences coding for proteins having the biological activity of husi-type i inhibitors biotechnological methods for the preparation of said proteins and pharmaceutical compositions containing said proteins | |
DE69725882D1 (de) | Adenovirus e4 proteine für induktion von zelltod | |
ATE460947T1 (de) | Verfahren zur sterilisation von biologischen präparaten | |
ATE495193T1 (de) | Bag3-antikörper zur nutzung in forschung, diagnose und der behandlung von krankheiten, an denen zelltod beteiligt ist | |
Balint et al. | Plasma constituent integrity in pre-storage vs. post-storage riboflavin and UV-light treatment–A comparative study | |
Blajchman | Protecting the blood supply from emerging pathogens: the role of pathogen inactivation | |
BR9810242A (pt) | Composições úteis como selante de fibrina | |
ATE237616T1 (de) | Verwendung von (1r,4s)-4-(6-amino-9h-purin-9-yl)- 2-cyclopenten-1-methanol in hbv | |
ATE165508T1 (de) | Verwendung von 2-methylamino-2-phenylcyclohexanon zur behandlung von infektionen und zur immunmodulation | |
UA10281C2 (uk) | Спосіб отримання речовини для лікування захворювань підшлункової залози | |
UA23145A (uk) | Спосіб визhачеhhя активhості бромелаїhу | |
ATE46360T1 (de) | Plasminogenaktivator fuer menschliches gewebe, diesen aktivator enthaltende pharmazeutische zusammensetzungen, verfahren zur herstellung des aktivators sowie dna und transformierte zellzwischenprodukte hierfuer. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |